Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Sector: Healthcare; Industry: Biotechnology

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. Iovance Biotherapeutics, Inc. has collaboration agreements with Moffitt, M.D. Anderson Cancer Center, Ohio State University, and MedImmune; and research collaboration with Cellectis S.A. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2016-08-25 Hillsberg Sanford Director Sell 54,000 $8.95 $483,412 No
2016-08-22 Hillsberg Sanford Director Sell 54,000 $9.11 $491,740 No
2015-09-08 Hillsberg Sanford Director Sell 32,500 $6.99 $227,085 No
2015-08-03 Hillsberg Sanford Director Sell 32,500 $8.15 $264,875 No
2015-05-06 Hillsberg Sanford Director Sell 50,000 $10.00 $500,000 No

Insider Smart

Enphase Energy, Inc (ENPH) - Watch for CEO Kothandaraman Badrinarayanan and CFO Branderiz Eric, their trading have a good pattern you can't miss, very well timed buy low and sell high.

Insider Smart

Delta Airlines (DAL) - From an insider's perspective: airlines are the first ones to go under due to the pandemic. A lot of concerns were raised on possible bankruptcy especially amid by the dump from Buffett. However, insiders of Delta were bold enough to buy when Buffett was fear. And Delta is the only airline bought by insiders post-Buffett-dump.